Advertisement
UK markets close in 1 hour 37 minutes

  • FTSE 100

    8,130.02
    +51.16 (+0.63%)
     

  • FTSE 250

    19,789.26
    +187.28 (+0.96%)
     

  • AIM

    755.42
    +2.30 (+0.31%)
     

  • GBP/EUR

    1.1675
    +0.0018 (+0.16%)
     

  • GBP/USD

    1.2510
    -0.0001 (-0.01%)
     

  • Bitcoin GBP

    51,494.91
    +838.23 (+1.65%)
     

  • CMC Crypto 200

    1,328.78
    -67.75 (-4.85%)
     

  • S&P 500

    5,094.32
    +45.90 (+0.91%)
     

  • DOW

    38,246.63
    +160.83 (+0.42%)
     

  • CRUDE OIL

    84.03
    +0.46 (+0.55%)
     

  • GOLD FUTURES

    2,351.40
    +8.90 (+0.38%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,101.17
    +183.89 (+1.03%)
     

  • CAC 40

    8,075.48
    +58.83 (+0.73%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

BUZZ-Genus: top-flight broker upgrades

Reuters - UK Focus

(Amends number of brokerages in fifth bullet (3 of 6))

** British animal genetics firm Genus (Other OTC: GENSF - news) up 5.3 pct, top of FTSE 250 after Liberum upgrades stock to "buy" from "hold", raises TP to 1750p from 1500p

** Analysts, rated at five stars for recommendation accuracy on Genus per StarMine, say co's business should be "fairly immune" from Brexit; only 10 pct of co's sales are from UK and a weaker sterling should boost profits by 7 pct

** Liberum also points to 3 new technologies which should transform co's growth (sexed semen, IVF in cattle and gene editing)

** Analysts say current trading is solid with robust US and China hog markets offsetting weaker conditions in Latam and dairy

** 3 of 6 brokerages rate the stock "buy" or higher, 3 "hold"; median TP is 1525p according to Thomson Reuters Eikon data (RM (LSE: RM.L - news) :pranav.kiran@thomsonreuters.com@reuters.net)